Stock Code: 002370 Stock Abbreviation: Asia-Pacific Pharmaceutical Announcement No.: 2026-025
Zhejiang Asia-Pacific Pharmaceutical Co., Ltd. Announcement on Independent Directors Obtaining Qualification Certificates
This company and all members of the board of directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and there are no false records, misleading statements, or major omissions.
Zhejiang Asia-Pacific Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held its first extraordinary general meeting of shareholders in 2026 on February 9, 2026. The proposal for the election of independent directors for the eighth board of directors was deliberated and approved. The meeting agreed to elect Ms. Sheng Tianqi as an independent director of the eighth board of directors. Her term of office shall commence from the date of approval by the first extraordinary general meeting of shareholders of the Company in 2026 until the expiration of the term of the eighth board of directors.
As of the date of the notice for the first extraordinary general meeting of shareholders in 2026, Ms. Sheng Tianqi had not yet obtained her independent director qualification certificate. In accordance with the relevant regulations of the Shenzhen Stock Exchange, Ms. Sheng has undertaken in writing to participate in the next independent director training and obtain the independent director qualification certificate recognized by the Shenzhen Stock Exchange.